The Drug Enforcement Administration (DEA) has announced that it will begin accepting applications this week for medical marijuana businesses to apply for federal protections being granted under the Trump administration’s cannabis rescheduling process.

Acting Attorney General Todd Blanche said he is immediately moving medical marijuana from Schedule I to Schedule III, which includes drugs like ketamine, Tylenol with codeine and anabolic steroids.

WASHINGTON - Acting Attorney General Todd Blanche announced Thursday that state-licensed medical cannabis and FDA-approved marijuana products will immediately be reclassified as less-dangerous drugs.

My stance on this issue has been clear. I remain committed to combatting the growing public health and safety threat marijuana poses.” By Zach Wendling, Nebraska Examiner After the Trump administration federally downgraded medical marijuana to a less dangerous classification of drug on Thursday,

The order places FDA-approved products containing marijuana and state-regulated medical marijuana products at a lower drug classification.

He described marijuana as a "very complicated subject" and noted that he had concerns about its broader impact.